Skip to main content
. Author manuscript; available in PMC: 2022 Mar 2.
Published in final edited form as: Am J Clin Oncol. 2018 Jun;41(6):581–587. doi: 10.1097/COC.0000000000000327

Table 4.

Reported reasons for clinical trial non-participation among AYA cancer patients, AYA HOPE study

Reason N (%)*
Any 29 (65.9)
Concern about involvement with clinical trials
    Worried that treatment was insufficiently tested 17 (38.6)
    Worried about side effects 14 (31.8)
    Worried about being treated like guinea pig 7 (15.9)
    Worried about receiving placebo 7 (15.9)
    Worried about having to switch doctors 7 (15.9)
    Did not think a trial would help 6 (13.6)
    Any concern reason 25 (56.8)
Problems with access to clinical trials
    Were too sick to enroll in a trial 8 (18.2)
    Could not find a trial nearby 6 (13.6)
    Insurance would not pay for all or part of trial #
    Any access reason 9 (20.5)
Both concern and access reason 5 (11.4)
*

Percentages are based on 44 patients who reported knowing that a clinical trial was available for their type and stage of cancer, but who did not participate in a trial (either by self-report or medical record abstraction). Percentages for individual reasons or groups of reasons do not sum to 100% because patients were asked to select all reasons that applied.

#

Data not shown due to cell size <5